Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
about
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyCCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck.Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis inductionHonokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression.Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expressionE-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes.Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.Honokiol targets mitochondria to halt cancer progression and metastasis.Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling.Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus.Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells.Phyto-polyphenols as potential inhibitors of breast cancer metastasis.
P2860
Q27003190-AF71D597-5B6F-44CA-8B2D-8FEE386DA5D1Q34487441-84BB57FB-3150-4452-AB2C-34D7A958F0C8Q35969702-EDAAC413-BB2F-49F5-A980-9AEEA87E69CDQ36140810-C327BD34-9EAB-442C-A1F7-A87B09389EA3Q36557474-076322A6-2C25-4354-9916-AC70C54F24FAQ37084539-2A8EBBD8-D995-43A2-A7D2-A68C3B456569Q37269104-C757F081-5BE1-4F14-AA61-EE71977BB5ABQ37536575-5BA413E5-9688-4F1A-9F7D-D7E3F896756BQ37576027-404421B5-69D4-4EE0-854C-5E319202242DQ37623392-02F5BF3B-0478-4AA4-8798-912430E04EEDQ37668174-E393B151-5DFD-4692-9B44-FD4B215B5477Q37668555-4CB6EEC0-28CE-4595-9DBB-43554CC3DE4BQ38228491-84EA777B-D90B-4FAA-8549-D006C915DD30Q38684517-7B39D117-D112-47F8-8DB2-229023F0A510Q38858961-004FAB99-621E-4BBD-B599-EA4DDBBECA1FQ38890499-0A8180AA-0732-4E11-90FF-6E87F03D0991Q38913258-BBF093B5-F51F-4B33-A787-243DF0705402Q39023307-9C8D42BC-793D-47F6-B080-27D0BFD22B1CQ41702001-816703E6-45AD-4A68-970A-B82E6C7D9293Q46477608-45620944-1369-42A5-81B8-37687977A455Q47866372-DB31B401-326B-4C59-A88F-53EE26438B82Q52679351-20BFCB6A-A950-40E2-9900-99D7B6D6EC7AQ55491670-32AAEFA9-CE83-401C-8152-C08C8AF3CA0B
P2860
Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@ast
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@en
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@nl
type
label
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@ast
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@en
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@nl
prefLabel
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@ast
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@en
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@nl
P2093
P2860
P1433
P1476
Honokiol inhibits epithelial-m ...... iption 3/Zeb1/E-cadherin axis.
@en
P2093
Arumugam Nagalingam
Dipali Sharma
Jack L Arbiser
Michael Y Bonner
Neeraj K Saxena
P2860
P304
P356
10.1016/J.MOLONC.2014.01.004
P50
P577
2014-01-15T00:00:00Z